Detalhe da pesquisa
1.
Radar-Guided Localization and Resection for Metastatic Nodal and Soft Tissue Melanoma: A Single-Institution Retrospective Study.
Cancer Control
; 31: 10732748241237907, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429650
2.
Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma.
Cancer Control
; 31: 10732748241246898, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38605434
3.
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
Ann Surg
; 277(5): e1106-e1115, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129464
4.
Recurrence Patterns for Regionally Metastatic Melanoma Treated in the Era of Adjuvant Therapy: A Systematic Review and Meta-Analysis.
Ann Surg Oncol
; 30(4): 2364-2374, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479663
5.
Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Ann Surg Oncol
; 30(11): 6340-6352, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481487
6.
Grade of Primary Cutaneous Leiomyosarcoma Dictates Risk for Metastatic Spread and Disease-Specific Mortality.
Cancer Control
; 30: 10732748231206957, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37876208
7.
Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series.
Cancer Control
; 30: 10732748231155699, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36764930
8.
Lymphoscintigraphy Using Tilmanocept Detects Multiple Sentinel Lymph Nodes in Melanoma Patients.
Cancer Control
; 30: 10732748231153775, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36705261
9.
Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: A multicenter cohort study.
J Am Acad Dermatol
; 88(1): 52-59, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184008
10.
Reflectance confocal microscopic visualization of melanocytic bodies in the stratum corneum overlying acral lentiginous melanoma.
Lasers Surg Med
; 55(3): 253-256, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883986
11.
Assessing the Efficacy of Imiquimod Use in Patients With Persistent Locally Advanced Melanoma In Situ
J Drugs Dermatol
; 22(5): 457-464, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133478
12.
Is the presence of tumor-infiltrating lymphocytes predictive of outcomes in patients with melanoma?
Cancer
; 128(7): 1418-1428, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35103302
13.
External Validation of a Dutch Predictive Nomogram for Complete Response to T-VEC in an Independent American Patient Cohort.
Ann Surg Oncol
; 29(3): 1637-1644, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34816368
14.
Is There a Relationship Between TILs and Regression in Melanoma?
Ann Surg Oncol
; 29(5): 2854-2866, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064332
15.
Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study.
Ann Surg Oncol
; 29(9): 5937-5945, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562521
16.
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.
Ann Surg Oncol
; 29(11): 7033-7044, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867209
17.
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience.
Ann Surg Oncol
; 29(2): 791-801, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648098
18.
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
Ann Surg Oncol
; 29(6): 3694-3708, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089452
19.
Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survival.
J Surg Oncol
; 125(2): 229-238, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34535899
20.
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Cancer
; 127(13): 2251-2261, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826754